“Rising Prevalence of Cardiovascular Disease”
The rising prevalence of cardiovascular disease is a major driving force behind the growth of the Europe resting Electrocardiograph (ECG) market, as heart conditions such as arrhythmias, heart failure, and coronary artery disease are becoming more common due to trends such as aging populations, sedentary habits, and lifestyle-related risks such as poor diet and smoking. Cardiovascular diseases remain a leading cause of mortality and morbidity in Europe, heightening the need for early detection and ongoing monitoring of heart health. Resting ECGs are crucial in diagnosing heart abnormalities by recording the heart's electrical activity in a non-invasive, quick, and cost-efficient manner, making them an essential tool in both primary and specialized care. As healthcare providers follow trends toward improving patient outcomes through early diagnosis and preventative care, demand for these devices continues to rise, spurred further by public health campaigns and investments in improving cardiovascular health across the region. The growing cardiovascular disease burden, alongside these technological and healthcare trends, is driving the expansion of the ECG market.
